Parameter
| Biomarker | CCAT2 | Full name | Colon Cancer Associated Transcript 2 | Molecular Type | Nucleic acid (lncRNA) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Imatinib treatment response prediction |
| Disease | Chronic Myeloid Leukemia(CML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Peripheral blood mononuclear cells (real-time reverse transcription PCR) | ||
| Pathobiological Mechanisms | Highly expressed in CML patients, associated with treatment response, spleen volume, and EUTOS score | ||||
| Clinical Availability Status | Research verification: High expression associated with imatinib resistance. | ||||
| Notes and Dynamics | Can serve as a molecular biomarker for predicting treatment response in chronic-phase CML patients. | ||||